Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RNAZ

TransCode Therapeutics Inc

Jun 09 • 04:00PM ET

4.98

-0.11 -2.16 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: LNAI APRE BCDA BIVI CALC CVM GOVX KAPA KPRX NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-48.65	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	-5.77%
Market Cap	4.74M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.86M	Perf Month	-31.97%
Enterprise Value	135.17M	PEG	-	EPS next Q	-	Inst Own	3.25%	Short Float	3.27%	Perf Quarter	-48.45%
Income	-43.70M	P/S	-	EPS this Y	-	Inst Trans	2.53%	Short Ratio	0.56	Perf Half Y	-42.16%
Sales	0.00M	P/B	3.65	EPS next Y	-	ROA	-47.38%	Short Interest	0.03M	Perf YTD	-27.09%
Book/sh	1.36	P/C	0.37	EPS next 5Y	-	ROE	-52.14%	52W High	20.99 -76.27%	Perf Year	-33.60%
Cash/sh	13.50	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-27.93%	52W Low	3.82 30.37%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	23.12% 13.66%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	95.40%	Oper. Margin	-	ATR (14)	0.73	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.11	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	32.74	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.11	EPS Q/Q	69.67%	SMA20	-14.20%	Beta	1.26	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-32.24%	Rel Volume	0.41	Prev Close	5.09
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-46.56%	Avg Volume	50.35K	Price	4.98
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	20,531	Change	-2.16%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)